EVALUATION OF ANTI-CYCLIC CITRULINATED PEPTIDE (ANTI-CCP) ANTIBODIES AGAINST RHEUMATOID FACTOR (RF), FOR THE EARLY DIAGNOSIS OF RHEUMATOID ARTHRITIS IN PATIENTS ATTENDING THE RH IMPERIAL GESTIÓN 2021 CLINICAL LABORATORY

Authors

  • R MAMANI CARATA Caja Nacional de Salud Hospital Obrero Nº11 Jaime Mendoza Distrital Uncia
  • L. E ALVARADO-ARNEZ Caja Nacional de Salud Hospital Obrero Nº11 Jaime Mendoza Distrital Uncia

Keywords:

Rheumatoid arthritis, anti-CCP

Abstract

Rheumatoid arthritis is a disease of worldwide impact that affects quality of life and work productivity, and is considered disabling. Over time, sufferers require third-party assistance.

Downloads

Published

2024-12-21

How to Cite

MAMANI CARATA, R., & ALVARADO-ARNEZ, L. E. (2024). EVALUATION OF ANTI-CYCLIC CITRULINATED PEPTIDE (ANTI-CCP) ANTIBODIES AGAINST RHEUMATOID FACTOR (RF), FOR THE EARLY DIAGNOSIS OF RHEUMATOID ARTHRITIS IN PATIENTS ATTENDING THE RH IMPERIAL GESTIÓN 2021 CLINICAL LABORATORY. Bio Scientia, 7(16), 31–32. Retrieved from https://revistas.usfx.bo/index.php/bs/article/view/1809

Issue

Vol. 7 No. 16 (2024): MEMORIA III CONGRESO NACIONAL CIENTÍFICO OWSD BOLIVIA 2024

Section

ARTÍCULOS ORIGINALES